New Approach for Treating Kaposi Sarcoma

A sugar-loving protein boosts the growth of Kaposi sarcoma tumors, states research published in Journal of Experimental Medicine. Interfering with these sugary interactions inhibited growth of Kaposi sarcomas in mice, hinting at the potential for new treatment strategies in humans.

KS is a cancer that is associated with infection with a herpes virus called HHV-8 and is prevalent in HIV patients. Effective antiretroviral drugs have decreased the incidence of KS, but the cancer eventually progresses in many patients and treatment options are limited.

Cancer Key Facts and Statistics
Cancer is an abnormal cell growth and it can destroy other body tissues. 1 in 6 deaths that occur in the world is due to cancer. Here are some key facts and statistics about cancer

A carbohydrate-binding protein called galectin-1 is released by a variety of tumors and promotes their growth and metastasis. A group of researchers at the University of Buenos Aires in Argentina now finds that blocking galectin-1 in mice bearing established Kaposi sarcomas slowed tumor growth in part by suppressing the formation of blood vessels that feed the tumor.

If the same holds true in humans, drugs targeting galectin-1 could provide new treatment options for patients with KS. These drugs might also hold promise for other diseases characterized by aberrant blood vessel growth, including macular degeneration and cardiovascular diseases.

Source-Eurekalert

Quiz on HIV Symptoms
Do you know that there are symptoms for each stage of HIV/AIDS? Learn more from our HIV Symptom Quiz but here’s a disclaimer – never go by symptoms alone. Symptoms only indicate the progression of the disease, while only a medical test can confirm it.

Survival in Sarcoma Patients Predicted by Early PET Response to Neoadjuvant Chemotherapy
Survival in patients with soft tissue sarcomas can be predicted via an early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy.

Enzyme-Inhibiting Molecule Effective In Sarcoma Treatment
US researchers have identified MK 1775 as a possible molecule that could be used in the treatment of sarcomas, especially the type affecting children.